2.63
-0.22 (-7.72%)
Penutupan Terdahulu | 2.85 |
Buka | 2.82 |
Jumlah Dagangan | 167,190 |
Purata Dagangan (3B) | 192,853 |
Modal Pasaran | 15,489,438 |
Harga / Jualan (P/S) | 0.640 |
Harga / Buku (P/B) | 2.02 |
Julat 52 Minggu | |
Tarikh Pendapatan | 12 May 2025 - 16 May 2025 |
Margin Keuntungan | -86.19% |
Margin Operasi (TTM) | -68.52% |
EPS Cair (TTM) | -4.99 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 16.90% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 21.44% |
Nisbah Semasa (MRQ) | 1.44 |
Aliran Tunai Operasi (OCF TTM) | -12.50 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.98 M |
Pulangan Atas Aset (ROA TTM) | -60.87% |
Pulangan Atas Ekuiti (ROE TTM) | -325.98% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (US) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | Vivos Therapeutics, Inc. | Bercampur | - |
AISkor Stockmoo
Konsensus Penganalisis | NA |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | -1.5 |
Osilator Teknikal | -2.5 |
Purata | -2.00 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 8.00% |
% Dimiliki oleh Institusi | 13.70% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tarikh | Jenis | Butiran |
---|---|---|
31 Mar 2025 | Pengumuman | Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update |
28 Mar 2025 | Pengumuman | Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call |
24 Feb 2025 | Pengumuman | Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide |
18 Feb 2025 | Pengumuman | Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |